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Abstract
Genome-wide association studies are a powerful approach used to identify common variants for complex disease.
However, the traditional genome-wide association methods may not be optimal when they are applied to rare
variants because of the rare variants’ low frequencies and weak signals. To alleviate the difficulty, investigators have
proposed many methods that collapse rare variants. In this paper, we propose a novel ranking method, which we
call stability selection based on random collapsing, to rank the candidate rare variants. We use the simulated mini-
exome data sets of unrelated individuals from Genetic Analysis Workshop 17 for the analysis. The numerical results
suggest that the selection based on a random collapsing method is promising for identifying functional rare
variants in genome-wide association studies. Further research to examine the error control property of the
proposed method is underway.
Background
Genome-wide association studies (GWAS) are a powerful
approach to identifying common variants associated with
complex disease under the common disease/common
variant hypothesis. This hypothesis assumes that com-
mon variants of small to modest effect are responsible
for common diseases [1]. However, recent studies have
revealed that the common variants explain only a small
proportion of the heritability [2]. Some studies suggest
that rare variants, typically defined as variants with minor
allele frequency (MAF) less than 5%, are more likely to
be functional variants [3,4]. This leads to the hypothesis
that the complex disease is associated with both common
and rare variants. However, rare variants were not the
focus in early GWAS because of the cost of the genotyp-
ing technology. Recently, next-generation sequencing
technologies have provided cost-effective procedures to
detect rare variants and have raised the challenge of how
to effectively identify functional rare variants in GWAS.
Many studies have shown that standard statistical meth-
ods are not appropriate for identifying functional rare var-
iants because of these variants’ low frequencies and weak
signals. To alleviate the difficulty, investigators have pro-
posed collapsing methods, which collapse rare variants
within a genetic region of interest, and these methods
have become popular (e.g., [5-9]). By collapsing multiple
rare variants, the association signals within the region of
interest can be enriched and then standard association
tests can be applied; see Dering et al. [8] for an overview.
H e r e ,w eb r i e f l yd e s c r i b et h ec o m b i n e dm u l t i v a r i a t ea n d
collapsing (CMC) method proposed by Li and Leal [9]. To
perform the CMC method, rare variants are first divided
into subgroups by some predefined criterion (say, MAF);
then variants are collapsed within each subgroup; finally, a
multivariate test is applied. However, the choice of the col-
lapsing criterion seems to be subjective, and an inap-
propriate collapsing criterion may result in low power.
In this paper, instead of predefining a collapsing criter-
ion, we propose a novel ranking method that is based on
random collapsing. We call this method stability selec-
tion based on random collapsing (SORC). The proposed
method is applied to the simulated mini-exome data sets
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Analysis Workshop 17 (GAW17). The numerical results
demonstrate that this method can recover many true
functional rare variants in the simulation models.
Methods
Collapsing methods
Suppose that in a genome-wide association study there
are N individuals and P rare variants located in K genes.
According to Li and Leal [9], the rare variants within
gene k are divided into Jk subgroups based on some pre-
defined criterion (say, MAF). In each subgroup, the rare
variants are collapsed into an indicator variable:
Xkj , =
⎧
⎨
⎩
1
0
if rare variants are present,
otherwise,
(1)
where k =1 ,…, K and j =1 ,…, Jk. For those genes
with only one variant, no collapsing is necessary. Based
on these indicator variables, statistical analysis, such as
univariate tests, multivariate tests, and linear regression,
can be conducted to identify the functional rare variants.
Random collapsing
To illustrate the idea of random collapsing, let Jk =2( k =
1, …, K) for simplicity. Assume that there are Mk rare
variants within gene k.F i r s t ,a ni n t e g e rSk is randomly
drawn from {1, 2, …, Mk}. Second, Sk rare variants are
randomly selected from Mk rare variants as the first sub-
group, and the rest of the rare variants constitute the sec-
ond subgroup. Third, the rare variants in each subgroup
are then collapsed into an indicator variable by means of
a coding system (Eq. (1)). Finally, standard statistical ana-
lyses, such as univariate tests, multivariate tests, and lin-
ear regression, can be conducted based on these
indicator variables. As opposed to the CMC method,
which requires a predefined collapsing criterion, the pro-
posed random collapsing process circumvents the diffi-
culty by repeating the random collapsing multiple times,
and a ranking method based on stability selection across
all replications can be developed.
SORC method
In statistical literature, original stability selection [10] is a
method that combines a random subsampling procedure
with some variable selection algorithm, under the ratio-
nale that important variables are more likely to be
selected across different subsamples. Borrowing the idea
of stability selection, in the proposed SORC method we
combine the random collapsing procedure with some
variable selection algorithm, say, the least absolute
shrinkage and selection operator (LASSO) [11]. Note that
the SORC method is different from stability selection
[10] in that the randomness is imposed on the collapsing
criteria instead of subsampling.
When the SORC procedure is performed, for each
repetition of the random collapsing, the rare variants in
each gene are randomly collapsed into two indicator
variables. Then the LASSO is used to select a subset of
variants by minimizing:
YX U −− + + () bg l b g
21 1 , (2)
where Y is the vector of phenotypes, X is the matrix of
collapsed indicator variables, U is the matrix of uncol-
lapsed common variants, b and g are linear coefficient
vectors for X and U, respectively. The regularization
parameter l is chosen using the cross-validation proce-
dure, and the variants being selected are recorded. After
R repetitions of the random collapsing, for each variant,
the relative frequency that it survives the LASSO selec-
tion is obtained. According to Meinshausen and Buhl-
mann [10], this relative frequency is called stability. A
list of ranked variants can then be obtained by means of
the ordered stabilities. We can report those variants
with the largest T (say, top 10 or 15) stabilities as sus-
pected functional variants, which are suspected to be
associated with the phenotype of interest. Therefore the
proposed SORC method is essentially a ranking method
that ranks the rare variants based on their correspond-
ing selection stability. However, if one is interested in
estimating the type I error (or controlling the family-
wise error rate), then further research is needed for
determining T.
Results and discussion
We analyzed the mini-exome data set of unrelated indi-
viduals simulated by GAW17 following the pilot3 study
of the 1000 Genomes Project, which consists of 24,487
autosomal SNPs on 3,205 genes [12]. There are 21,355
rare variants, of which 13,572 are nonsynonymous.
There are 200 replicates of phenotypes, including one
disease trait and three quantitative traits (Q1, Q2, and
Q4) simulated from a selection of designated sequence
variants, and other covariates such as sex, age, and
smoking status. Throughout our analysis, we coded each
variant as 0 or 1 according to the absence or presence,
respectively, of minor alleles.
We applied the SORC method to Q1. The linear
model is assumed to be the basic association model. We
entered only the nonsynonymous SNPs as candidate
variants in our model and did not include any covari-
ates. We defined the rare variants as the ones with MAF
< 5%. For each replicate of the simulated phenotypes,
we preformed 100 repetitions of the proposed random
collapsing; the LASSO procedure was implemented with
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genes ranked by the stabilities of the variants contained
within them, using the phenotype Q1 in the first simu-
lated replicate. The proposed method identified 39 var-
iants in the top 10 genes, among which 16 are true
functional variants used in the simulation model.
Table 2 shows the top 13 most identified genes for Q1
across all the 200 simulated replicates, ranked by the num-
ber of times they were identified (genes ranked in the top
15 are treated as identified). Among the top 13 most iden-
tified genes, 4 contain true functional variants. Table 3
indicates the number of successful identifications of true
genes that contain at least one true functional variant for
Q1 across all 200 replicates. Although two true genes were
never detected for all replicates with the proposed method,
about half of the true genes were identified in most of the
replicates.
For comparison, we also applied three existing
approaches to the same data set. The first approach is
the single-marker test in which a univariate test is per-
formed to test each variant individually. The second
approach is the collapsing method, in which rare variants
in the same gene are collapsed by means of a coding sys-
tem (Eq. (1)) and then a univariate test is performed
based on the collapsed variables. The third approach is
the CMC method, in which rare variants are collapsed in
the same gene and common variants are kept the same
and then a multivariate test is applied to each gene.
These three approaches have been fully studied and com-
pared by Li and Leal [9]. For each approach, the variants
are ranked by −log10(P-value). Table 4 presents the top
10 genes with the highest ranked variants from the three
approaches. For all three methods, among the top 10
genes only gene FLT1 contains true functional variants.
Conclusions
Our proposed method provides a novel approach to rank-
ing suspected functional rare variants in GWAS. The idea
is motivated by the stability selection of Meinshausen and
Buhlmann [10]. The result is promising, but some ques-
tions still remain unanswered, for example, how many var-
iants should be selected as functional using the ranked
stabilities and whether or not there is an error control the-
orem for the family-wise error rate. In addition, the SORC
Table 1 Top 10 ranked genes for trait Q1 in replicate 1
Gene Functional SNPs MAF b
b Stability
c
FLT1
a C13S431 0.02 0.74 1
C13S522 0.03 0.62 1
C13S523 0.07 0.65 1
C13S320 <0.01 0.2 0.95
C13S524 <0.01 0.62 0.94
C13S399 <0.01 0.4 0.92
C13S567 <0.01 0.17 0.88
C13S505 <0.01 0.45 0.87
BRWD1 –– – 1
KDR
a C4S1884 0.02 0.3 0.97
C4S1889 <0.01 0.94 0.72
C4S1877 <0.01 1.08 0.67
C4S1890 <0.01 0.42 0.66
C4S1873 <0.01 0.58 0.64
C4S1874 <0.01 0.47 0.63
C4S1879 <0.01 0.62 0.63
C14ORF159 – 0.18 – 0.79
C1ORF122 – <0.01 – 0.7
ZNF502 – 0.24 – 0.79
VEGFA
a C6S2981 <0.01 1.2 0.62
HNRPUL1 – <0.01 – 0.58
FMNL3 – <0.01 – 0.56
AIF1 – 0.05 – 0.49
a Genes containing at least one true functional variant.
b True effect size in the simulated model.
c Estimated from 100 repetitions of randomized collapsing.
Table 2 Top 13 most identified
a genes for the trait Q1
across all 200 replicates
Rank Gene Number of times selected
1 FLT1
b 200
2 KDR
b 137
3 ARNT
b 60
4 TACC2 36
5 RAD54B 30
6 ACP1 28
7 C9ORF66 26
7 JAK1 26
9 CES1 24
9 HYAL3 24
9 OR2T34 24
9 LYPD2 24
9 VEGFA
b 24
a Genes ranked in the top 15 are treated as identified.
b Genes containing at least one true functional variant.
Table 3 Number of times the true genes for Q1 across all
200 replicates are identified
a
Gene Rank Number of times identified
FLT1 1 200
KDR 2 137
ARNT 36 0
VEGFA 92 4
VEGFC 54 9
ELAVL4 122 5
HIF3A 608 1
FLT4 – 0
HIF1A – 0
a Genes ranked in the top 15 are treated as identified.
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procedures (e.g., [14]) instead of the LASSO, and it can
also be constructed using other collapsing procedures
(e.g., [8]) instead of random collapsing. Hence further stu-
dies should be done to evaluate and compare the perfor-
mance of these alternatives.
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Table 4 Comparison of ranking approaches
Rank
a Single-marker test Collapsing method CMC method SORC method
1 FLT1
b TBX18 FLT1
b FLT1
b
2 OR2T34 FLT1
b TBX18 BRWD1
3 LRRK2 AMPD3 AMPD3 KDR
b
4 BRCA1 C8ORF31 C8ORF31 C14ORF159
5 PPP1R14BP1 SLCO1A2 ADAM7 C1ORF122
6 HSZFP36 ADAM7 TMEM67 ZNF502
7 C9ORF66 C9ORF66 SBF2 VEGFA
b
8 ABL2 AIF1 KIAA0802 HNRPUL1
9 AIF1 SBF2 AIF1 FMNL3
10 RUNX2 FARP1 FARP1 AIF1
a Genes are ordered by the rank of their SNPs’ −log10(p-value).
b Genes containing at least one true functional variant
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